Assessment of minimum target dose as a predictor of local failure after spine SBRT
-
Published:2024-06
Issue:
Volume:195
Page:110260
-
ISSN:0167-8140
-
Container-title:Radiotherapy and Oncology
-
language:en
-
Short-container-title:Radiotherapy and Oncology
Author:
Kowalchuk Roman O., Mullikin Trey C., Spears Grant M., Johnson-Tesch Benjamin A., Rose Peter S., Siontis Brittany L., Kun Kim Dong, Costello Brian A., Morris Jonathan M., Gao Robert W., Shiraishi SatomiORCID, Lucido John J., Olivier Kenneth R., Owen Dawn, Stish Bradley J., Waddle Mark R., Laack Nadia N., Park Sean S., Brown Paul D., Merrell Kenneth W.
Reference31 articles.
1. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial;Sahgal;Lancet Oncol,2021 2. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1–3) spine metastases: phase 2 results;Ryu;Pract Radiat Oncol,2014 3. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019 4. Surveillance or metastasis-directed therapy for Oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018 5. Cost-effectiveness of treatment strategies for spinal metastases;Kowalchuk;Pract Radiat Oncol,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|